Presented by
The Future Is Uninstalling It All Before the Smoothbrain Hits
TOP STORY
Not even a year after the US Food and Drug Administration announced it was using generative AI to speed up the drug review process, the agency has another…bold announcement.
SPONSORED
The Year-End Moves No One’s Watching
Markets don’t wait — and year-end waits even less.
In the final stretch, money rotates, funds window-dress, tax-loss selling meets bottom-fishing, and “Santa Rally” chatter turns into real tape. Most people notice after the move.
Elite Trade Club is your morning shortcut: a curated selection of the setups that still matter this year — the headlines that move stocks, catalysts on deck, and where smart money is positioning before New Year’s. One read. Five minutes. Actionable clarity.
If you want to start 2026 from a stronger spot, finish 2025 prepared. Join 200K+ traders who open our premarket briefing, place their plan, and let the open come to them.
By joining, you’ll receive Elite Trade Club emails and select partner insights. See Privacy Policy.
HEADLINES FROM TODAY
OF INTEREST
Well, how do you feel after using ChatGPT?
NEWS IN QUOTES
“I think it just looked opportunistic and sloppy.”
— Sam Altman, OpenAI imperator
Sam Altman Is Realizing He Made a Gigantic Mistake